- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 303/32 - Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
Patent holdings for IPC class C07D 303/32
Total number of patents in this class: 113
10-year publication summary
|
7
|
8
|
7
|
17
|
6
|
8
|
5
|
5
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Onyx Therapeutics, Inc. | 69 |
10 |
| QBiotics Pty Ltd | 29 |
10 |
| Kezar Life Sciences, Inc. | 12 |
5 |
| Western Washington University | 21 |
4 |
| Woods Hole Oceanographic Institution | 141 |
4 |
| The Regents of the University of California | 20108 |
3 |
| Lixte Biotechnology, Inc. | 64 |
3 |
| Marine Biological Laboratory | 22 |
3 |
| Quadriga Biosciences, Inc. | 22 |
3 |
| The United States Government AS represented by The Department of Veterans Affairs | 1209 |
3 |
| AstraZeneca AB | 2886 |
2 |
| Sumitomo Chemical Company, Limited | 9079 |
2 |
| Kaneka Corporation | 4614 |
2 |
| Northwestern University | 3418 |
2 |
| Cornell University | 3339 |
2 |
| Fresenius Kabi Oncology Limited | 66 |
2 |
| Givaudan SA | 1893 |
2 |
| National University Corporation Hokkaido University | 1347 |
2 |
| University of Rochester | 1315 |
2 |
| Launch-pharma Technologies, Ltd. | 4 |
2 |
| Other owners | 45 |